Navigation Links
Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing

DUBLIN, April 15, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing" report to their offering.


Isothermal Nucleic Acid Amplification Technologies (INAAT) discloses the promising trends in Nucleic acid testing and their applications in molecular diagnostics and laboratory research on a global scale. The World Health Organization (WHO) proposes that, an ideal diagnostic test that is suitable for developing countries, should be Affordable, Sensitive, Specific and User-friendly (simple to perform in a few steps with minimal training), Robust and rapid (results available in minutes), Equipment free and Deliverable to the end user (ASSURED). Nucleic acid amplification tests targeting pathogen markers have high sensitivity and specificity, but generally fail to meet the ASSURED guidelines in terms of affordability, rapidity, and being equipment free. However, INAAT has recently attracted the scientific community due to their operation in single temperature and distinct features by meeting the ASSURED guidelines. With fine-tunings in the amplification methodology, a variety of INAAT types are discovered each being independent, driving the diagnostic platform towards Point-Of-Care (POC) testing at low resource settings.

This research report provides in-depth details about technology evolution, and innovation trends across the industry, technology investment potential and competitive market landscape. The analyses ensuing out of this research service may provide, useful insights for end users, while prioritizing the appropriate choice of modality for nucleic acid testing in research and diagnostics.

In brief, this research report provides:

A detailed description of the global technology developments and evolving trends, in the INAAT field with key prominence on product innovations by industries, and collaborative efforts by the academic research institutions.

A comprehensive picture of the different types of INAAT platforms available with an exhaustive overview of their application prospective.

  • An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of INAAT during the period from 2012 to 2017.
  • Market size - Global market forecast for the next 5 years, including demand side analysis and strategic recommendations for technology/product developers.
  • Prioritized INNAT types through the Analytical Hierarchy Process (AHP) based on competitive benchmarking, technology management strategies and technology roadmap.

Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants.

Main Driver:

Global prevalence of infections and cancer: An effective diagnosis of diseases is the first step towards personalized medicine. Over 1 billion people are afflicted owing to infectious diseases and cancer especially in the tropical/developing countries where access to diagnostics labs are limited.

Main Restraint:

Conservative mindset for INAAT usage: Most of the end users perceive PCR to be more reliable standard for detection. This is true for some of the developing and developed countries. Owing to the lack of knowledge or awareness about the advances in the latest technological developments in INAAT. This is perceived as a restraint for INAAT market

Main Challenge:

Market penetration of INAAT: Penetrating new markets in China, India and Middle could be competitive for INAAT based players due to high competition from players who are already suppliers of PCR based products. However this could be a big advantage for PCR diagnostic product manufacturers, since they have capability to adopt these new technologies.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Isothermal Nucleic Acid Amplification Technologies (INAAT) - Technology Landscape Analysis

4 Technology Investment Potential

5 INAAT - Market Landscape Analysis

6 INAAT - Technology Adoption Potential & Development By Geography

7 Competitive Landscape

8 Patent Analysis And Research Trend (Publications) 2007-2012


10 Analyst Insights & Recommendations

11 Company Profiles


For more information visit Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets.

Research and Markets
Laura Wood , Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
2. ZyGEM Teams With TATAA Biocenter To Distribute Its Innovative Nucleic acid Extraction Kits
3. Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics
4. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
5. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
6. UV Flu Technologies Expands Its International Footprint
7. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
8. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
9. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
10. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
11. Senesco Technologies, Inc. to Webcast, Live, at on December 1st
Post Your Comments:
(Date:11/30/2015)... 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") ... Wong to its Board of Directors to replace Dr. ... a wealth of experience as co-founder of Resverlogix, with expertise ... --> --> Dr. Wong remarked, "I ... directors. Zenith,s long standing expertise in epigenetics and the advanced ...
(Date:11/30/2015)... -- TapImmune, Inc. (TPIV), a clinical-stage ... and gene-based immunotherapeutics and vaccines for the treatment of ... presenting at the 8 th Annual LD Micro ... PT. Dr. John N. Bonfiglio a TapImmune ... presentation and will join TapImmune management in meeting with ...
(Date:11/30/2015)... 2015  Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW ... therapies for solid tumor cancers, announced today that the ... and the Company welcomes Neil Woodford,s call ... anonymous internet report on NW Bio.  The Company,s Board ... Powers stated, "We agree with Mr. Woodford that, ...
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon is pleased to announce ... offered in symposia, oral sessions, workshops, awards, and posters. The core of ... applications such as, but not limited to, biotechnology, biomedical, drug discovery, environmental, food ...
Breaking Biology Technology:
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):